News

Filter

Current filters:

None

8676 to 8685 of 95865 results

Lilly’s Alimta shows benefit in hard-to-treat lung cancer patients

28-09-2011

US drug major Eli Lilly (NYSE: LLY) says that a new subgroup analysis of data from the pivotal Phase…

AlimtaEli LillyOncologyPharmaceuticalResearch

Ipsen enters deal with Photocure to commercialize Hexvix

28-09-2011

French drugmaker Ipsen (Euronext: IPN) has entered into a partnership with Norway-based Photocure (OSE:…

HexvixIpsenLicensingOncologyPharmaceuticalPhotocure

Mesoblast and Lonza establish strategic global manufacturing alliance for stem cell products

28-09-2011

Australian regenerative medicine company Mesoblast (ASX: MSB) and Switzerland-based Lonza Group (SWS:…

BiotechnologyLicensingLonzaMesoblastPharmaceutical

US FDA communicates concern about drospirenone-containing birth control pills

27-09-2011

The US Food and Drug Administration (FDA) is informing the public that it has not yet reached a conclusion,…

BayerDrospirenone and Ethinyl EstradiolNorth AmericaPharmaceuticalRegulationReproductiveYasminYaz

HRT therapy appears to increase risk of hospitalization from severe asthma attacks

27-09-2011

Women taking postmenopausal hormone replacement therapy (HRT) may have an increased risk of severe asthma…

PharmaceuticalRegulationReproductiveResearch

Generic drugs market to reach $358 billion by 2016

27-09-2011

This is a time of growth and change for the generic pharmaceuticals sector, according to a new report…

GenericsGlobalMarkets & Marketing

German pharma counts cost of drug pricing reforms

27-09-2011

Recent government drug pricing reforms have cost the German pharmaceutical industry billions of euros,…

EuropeFinancialPharmaceuticalPricingResearch

8676 to 8685 of 95865 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top